ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0267

Psychosocial and Health Measures in Systemic Lupus Erythematosus: Before and During the COVID-19 Pandemic in the Georgian’s Organized Against Lupus Cohort

Charmayne Dunlop-Thomas1, Gaobin Bao1, S Sam Lim2 and Cristina Drenkard1, 1Emory University, Atlanta, GA, 2Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

Meeting: ACR Convergence 2021

Keywords: COVID-19, mental health, Minority Health, psychosocial factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Session Title: Psychology/Social Sciences Poster (0266–0267)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Disruptions of routines or livelihood and worry during the COVID-19 pandemic may have impacted systemic lupus erythematosus (SLE) patients in multiple ways. We explored pre- and during pandemic changes of SLE disease activity, general health, and psychosocial factors in a large and diverse cohort.

Methods: We examined longitudinal data from Georgians Organized Against Lupus (GOAL), a population-based cohort of adults from Atlanta, Georgia, with a validated diagnosis of SLE. All participants fulfilled 3 or more ACR classification criteria and had a final diagnosis of SLE by a board-certified rheumatologist. Participants responded to validated self-administered instruments on health outcomes at least annually. This study included participants who completed one survey before (2017-2019) and another survey during the pandemic (2020-2021). We explored changes in SLE disease activity, health, and psychosocial elements with the following measures: Systemic Lupus Activity Questionnaire (SLAQ), PROMIS short forms (Global physical and mental health, Depression, Emotional Support, Self-efficacy for managing symptoms, Self-efficacy for managing medications and treatments), Everyday Discrimination Scale, and Cohen’s Perceived Stress Scale. Changes in mean scores were assessed using a paired test (univariate analysis). Multivariate regression analysis was performed to further exam differences, with the adjustments for socio-demographics (age, gender, race, education), insurance status, disease damage, stress, and discrimination.

Results: We evaluated 852 participants (94% women, 81% Black, mean age 48). SLE-related characteristics included an average age of diagnosis of 32.2 years (SD ± 11.8), average disease duration of 15.5 years (SD ± 10.2), and over 50% with severe disease damage based on the Self-administered Brief Index of Lupus Damage (score ≥ 3). Overall, insurance categories remained without significant changes during the pandemic (Table 1). Except for global mental health, all measures showed significantly better mean scores during the pandemic than pre-pandemic. After adjustments for confounders, mean scores for emotional support and self-efficacy remained markedly better during the pandemic than before the pandemic (Figure 1). The original paired test showed no difference for global mental health; however, mental health was associated with significant worsened change after adjustments.

Conclusion: Our results in a diverse cohort with large numbers of socially vulnerable people show that participants reported improved confidence to manage symptoms, medications, and other treatments in challenging times. Additionally, they received more emotional support during the pandemic. However, global mental health deteriorated. We hypothesize that the stay-at-home pandemic recommendations allowed patients to seek out supportive resources and focus on self-management. Further observations post-pandemic will offer more insight regarding the mental health impact on SLE.


Disclosures: C. Dunlop-Thomas, None; G. Bao, None; S. Lim, Bristol Myers Squibb, 5, GlaxoSmithKline, 2, ACR, 4, AstraZeneca, 5, Pfizer, 2, UCB, 2; C. Drenkard, GSK, 1, 5.

To cite this abstract in AMA style:

Dunlop-Thomas C, Bao G, Lim S, Drenkard C. Psychosocial and Health Measures in Systemic Lupus Erythematosus: Before and During the COVID-19 Pandemic in the Georgian’s Organized Against Lupus Cohort [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/psychosocial-and-health-measures-in-systemic-lupus-erythematosus-before-and-during-the-covid-19-pandemic-in-the-georgians-organized-against-lupus-cohort/. Accessed January 30, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psychosocial-and-health-measures-in-systemic-lupus-erythematosus-before-and-during-the-covid-19-pandemic-in-the-georgians-organized-against-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences